Pfizer has extended the recent recall on Lipitor to an additional 38,000 bottles. This is after two recalls in the last three months of the drug, after a musty and moldy odor was found coming from the bottles. Back in August Pfizer recalled 140,000 bottles of Lipitor, and another 191,000 bottles just two weeks ago. This recent recall brings the total to 332,000 products.

The latest recall is for bottles of Lipitor containing 90 of the 40 milligram pills. Although studies have revealed that the musty odors coming from the bottles do not pose any significant risks to consumers, the recall is being initiated as a precautionary measure by the company. Pfizer said that the odor stemmed from a chemical called 2,4,6 tribromoanisole, also known as TBA. The chemical is used as a wood preservative, and was on the pallets used to transport the bottles, as well as store them.

A spokesman for Pfizer, ray Kerins stated, “The Lipitor recall won’t have a financial impact, customers who notice a smell can replace the bottle at their pharmacy without charge”.

Pfizer was founded in 1849, and is headquartered in New York City, New York. The Lipitor drug is the number one selling branded pharmaceutical in the world today.